N- {[(IR,4S,6R-3-(2-pyridinylcarbonyl)-3-az abicyclo [4.1.0] hept-4-yl] methyl}-2-heteroarylamine derivatives and uses thereof

Details for Australian Patent Application No. 2009324238 (hide)

Owner Glaxo Group Limited

Inventors Alvaro, Giuseppe; Amantini, David; Castiglioni, Emiliano; Di Fabio, Romano; Pavone, Francesca

Agent Davies Collison Cave

Pub. Number AU-A-2009324238

PCT Pub. Number WO2010/063662

Priority 61/236,302 24.08.09 US; 61/119,118 02.12.08 US

Filing date 30 November 2009

Wipo publication date 10 June 2010

International Classifications

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

A61P 25/22 (2006.01) Drugs for disorders of the nervous system

A61P 25/24 (2006.01) Drugs for disorders of the nervous system

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 417/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

16 June 2011 PCT application entered the National Phase

  PCT publication WO2010/063662 Priority application(s): WO2010/063662

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009324239-N- {[(IR,4S,6R-3-(2-pyridinylcarbonyl)-3-az abicyclo [4.1.0]hept-4-yl] methyl}-2-heteroarylamine derivatives and uses thereof

2009324228-Methods and uses involving Heme binding protein 1